Diagnosis and antibacterial treatment for community-acquired pneumonia in children during the COVID-19 pandemic
<p> <b>S.V. Zaitseva<sup>1,2</sup>, O.V. Zaitseva<sup>1</sup>, E.E. Lokshina<sup>1</sup></b> </p> <p> <b><sup>1</sup>A.I. Evdokimov Moscow University of Medicine & Dentistry, Moscow, Russian Federation</...
Main Authors: | S.V. Zaitseva, O.V. Zaitseva, E.E. Lokshina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LCC «Medicine-Inform»
2021-02-01
|
Series: | РМЖ. Мать и дитя |
Online Access: | http://wchjournal.com/upload/iblock/e56/e56f9e79798833973e53c3ac9581b4a9.pdf |
Similar Items
-
Community-acquired pneumonia in children in the era of the COVID-19 pandemic. What has changed?
by: Olga V. Zaytseva, et al.
Published: (2021-03-01) -
Community-acquired pneumonia in children: antibacterial therapy
by: Y. L. Mizernitsky
Published: (2013-12-01) -
Current guidelines for the selection of an antibacterial drug in children with community-acquired pneumonia
by: S. V. Zaytseva, et al.
Published: (2022-04-01) -
EXPERIENCE OF ADMINISTRATION OF MILK FORMULA «NESTOGEN 1» IN HEALTHY CHILDREN OF FIRST SIX MONTHS OF LIFE
by: O.V. Zaitseva, et al.
Published: (2008-04-01) -
EXPERIENCE OF ADMINISTRATION OF MILK FORMULA «NESTOGEN 1» IN HEALTHY CHILDREN OF FIRST SIX MONTHS OF LIFE
by: O.V. Zaitseva, et al.
Published: (2008-01-01)